coronavirida
famili
cluster
number
larg
rna
virus
share
sever
structur
function
featur
howev
member
famili
recogn
differ
cellular
receptor
exploit
differ
entri
rout
affect
speci
specif
virul
aim
studi
determin
human
coronaviru
enter
suscept
cell
use
confoc
microscopi
molecular
biolog
tool
visual
earli
event
infect
found
viru
employ
depend
endocytosi
entri
scission
viruscontain
vesicl
cell
surfac
dynamindepend
furthermor
vesicl
intern
process
requir
actin
cytoskeleton
rearrang
research
strove
broaden
understand
infect
process
futur
may
benefici
develop
potenti
therapeut
current
six
human
coronavirus
describ
wellknown
human
coronavirus
hcov
describ
almost
year
consid
repres
coronavirida
infect
human
emerg
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
follow
identif
reveal
virus
far
common
clinic
relev
previous
expect
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
prove
pathogen
frequent
cross
speci
border
may
pose
signific
healthcar
risk
infect
associ
respiratori
tract
ill
vari
sever
viru
consid
common
human
coronaviru
worldwid
highest
incid
winter
spring
month
due
genom
sequenc
similar
bovin
coronaviru
bcov
lesser
extent
canin
respiratori
coronaviru
caus
diseas
respect
anim
assum
zoonot
transmiss
human
occur
rel
recent
recent
common
ancestor
bcov
date
end
th
centuri
evolutionari
rate
estim
nucleotid
chang
per
site
per
year
coronaviru
entri
cell
complex
process
requir
seri
cellular
factor
first
viru
bind
attach
receptor
interact
result
increas
cell
surfac
densiti
viru
particl
facilit
interact
fusion
receptor
make
exampl
bovin
coronaviru
bind
acid
bind
oacetyl
sialic
acid
sarscov
bind
heparan
sulfat
proteoglycan
case
step
seem
redund
other
deplet
adhes
receptor
result
lack
interact
viru
cell
consequ
sever
decreas
viru
infect
nonetheless
presenc
adhes
factor
suffici
make
cell
permiss
coronavirus
util
broad
varieti
fusion
receptor
alphacoronavirus
use
aminopeptidas
n
cell
entri
except
similarli
sarscov
employ
human
angiotensinconvert
enzym
report
util
hla
class
molecul
sialic
acid
merscov
dipeptidyl
peptidas
wherea
receptor
remain
unknown
recognit
differ
receptor
impli
differ
cellular
tropism
also
differ
intern
rout
worth
mention
howev
recent
report
also
stress
import
cellular
factor
viru
tissu
specif
includ
tissuespecif
proteas
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
interact
receptor
begin
bind
may
induc
fusion
cellular
membran
case
event
preced
viru
intern
via
endocyt
rout
common
best
describ
rout
clathrindepend
endocytosi
path
use
repres
wide
rang
viral
famili
eg
human
enteroviru
human
metapneumoviru
rabi
viru
other
upon
receptor
recognit
viral
particl
dock
clathrinco
pit
format
initi
concert
action
protein
complex
consist
induc
curvatur
plasma
membran
recruit
adaptor
protein
nucleat
site
assembl
clathrin
unit
concentr
reach
critic
level
polymer
form
lattic
membran
structur
deepen
stabil
cargo
bud
vesicl
accompani
tubular
neck
format
amphiphysin
protein
attract
recruit
dynamin
polymer
gtp
depend
mode
final
cut
cargocontain
vesicl
cell
surfac
anoth
welldescrib
path
mediat
endocytosi
caveola
flaskshap
cholesteroland
sphingolipidrich
smooth
membran
invagin
stabil
load
caveola
cargo
result
recruit
cut
invagin
form
neutralph
vesicl
call
caveosom
vesicl
either
transfer
golgi
complex
endoplasm
reticulum
er
progress
earli
endosom
recent
besid
two
canon
pathway
numer
altern
rout
describ
includ
entosi
flotillindepend
entri
feme
mechan
aim
studi
map
entri
suscept
cell
first
confirm
viru
bind
cell
intern
via
endocytosi
subsequ
shown
particl
bind
cell
surfac
migrat
caveola
traffick
endosom
caveolinmedi
dynamindepend
rout
viru
intern
requir
unwind
actin
cortex
yet
actin
filament
requir
entri
enter
cell
via
endosom
first
determin
whether
viru
requir
endocytosi
viruscel
fusion
may
occur
cell
surfac
cell
preincub
nh
cl
subsequ
incub
viru
presenc
nh
cl
prevent
acidif
endosom
matur
afterward
media
refresh
remov
unbound
viru
particl
infect
carri
day
cours
monitor
flow
cytometri
shown
fig
addit
nh
cl
earli
infect
result
reduct
number
virusposit
cell
similarli
anoth
inhibitor
endocyt
compart
acidif
vacuolartyp
atpas
inhibitor
bafilomycin
limit
number
infect
cell
fig
order
confirm
observ
evalu
coloc
viru
particl
earli
endosom
marker
cell
overlaid
incub
synchron
entri
viral
particl
next
cultur
warm
enabl
intracellular
transport
viru
intern
subsequ
cultur
fix
permeabil
stain
specif
antibodi
visual
viral
protein
min
postinocul
pi
viru
particl
coloc
remain
close
proxim
cellular
membran
fig
b
time
virion
start
gradual
accumul
larger
less
abund
cluster
fig
eventu
enter
cell
determin
endocyt
rout
employ
coloc
virion
marker
differ
pathway
test
clearli
min
pi
viru
coloc
fig
prolong
coloc
consist
report
right
part
graph
show
cell
viabil
determin
xtt
assay
nh
cl
mm
nh
cl
nm
bafilomycin
control
pb
mock
infect
cell
v
infect
cell
data
present
mean
triplic
sampl
sd
determin
signific
differ
compar
group
singlefactor
analysi
varianc
anova
appli
p
valu
consid
signific
scientif
report
doi
kinet
caveola
transport
coloc
clathrin
note
supplementari
fig
order
valid
observ
cholera
toxin
b
ctb
conjug
fluorescein
isothiocyan
fitc
use
posit
control
depend
entri
fig
disrupt
caveola
hamper
entri
order
ensur
enter
cell
use
caveola
specif
inhibitor
endosom
pathway
use
caveola
form
membran
cluster
accompani
cholesterol
sphingolipid
consequ
caveolinmedi
entri
sensit
cholesterolbind
deplet
agent
nystatin
cell
preincub
compound
overlaid
viru
follow
incub
cell
fix
permeabil
immunostain
actin
viru
entri
evalu
use
confoc
microscopi
shown
fig
incub
nystatin
fig
c
result
signific
retent
viru
cell
surfac
prove
caveola
requir
viru
intern
cholera
toxin
use
refer
fig
g
previous
report
enter
cell
via
caveosom
inhibit
entri
fig
effect
ctb
fig
ensur
observ
effect
specif
silenc
express
cell
use
sirna
deliv
two
consecut
transfect
scrambl
sirna
use
control
twentyfour
hour
second
transfect
cell
incub
h
subsequ
cell
fix
permeabil
immunostain
visual
viru
cell
transfect
specif
sirna
protein
level
reduc
almost
assess
western
blot
scrambl
sirna
nt
influenc
protein
level
use
refer
household
gene
fig
origin
imag
membran
provid
supplementari
fig
viru
intern
cell
deplet
evalu
confoc
microscopi
shown
fig
viral
particl
retain
cell
surfac
cell
deplet
fig
effect
observ
control
cell
fig
e
test
whether
caveolinmedi
endocytosi
major
rout
entri
cell
preincub
nystatin
h
subsequ
infect
presenc
inhibitor
h
subsequ
medium
discard
remov
unbound
viru
particl
fresh
medium
appli
infect
carri
day
cours
monitor
flow
cytometri
obtain
result
clearli
show
nystatin
fig
significantli
affect
viru
infect
cell
order
ensur
observ
effect
result
cytotox
inhibitor
cell
viabil
test
xtt
assay
fig
entri
dynamindepend
determin
whether
entri
process
dynaminmedi
two
differ
dynamin
inhibitor
use
mitmab
interact
lipid
bind
ph
domain
dynamin
dynasor
noncompetit
inhibit
gtpase
activ
dynamin
obtain
result
show
dynamin
activ
requir
effect
entri
target
cell
fig
requir
actin
success
entri
order
studi
role
cytoskeleton
viru
entri
use
two
compound
known
affect
actin
cytoskeleton
briefli
cell
pretreat
jasplakinolid
cytochalasin
inocul
dextran
incub
condit
allow
intracellular
transport
subsequ
cultur
fix
permeabil
stain
specif
antibodi
visual
viru
particl
actin
cytoskeleton
confoc
imag
reveal
stabil
actin
cortex
jasplakinolid
result
inhibit
viru
entri
dextran
intern
may
suggest
actin
import
vesicl
format
viru
enter
cell
macropinocytosi
howev
analysi
cell
pretreat
cytochalasin
reveal
depolymer
actin
filament
inhibit
viru
entri
drastic
modul
viru
local
fig
viru
particl
local
nonstructur
actin
deposit
cell
cytoplasm
hand
dextran
intern
hamper
fig
inhibitor
drastic
limit
viru
infect
rate
shown
flow
cytometri
fig
inhibit
viru
entri
infect
observ
wortmannin
inhibitor
known
hamper
macropinocytosi
supplementari
fig
consid
micropinocytosi
may
independ
made
effort
ensur
viru
use
pathway
entri
briefli
use
dextran
kda
cargo
report
enter
cell
micropinocytosi
test
coloc
virion
viru
entri
shown
supplementari
fig
strong
coloc
dextran
observ
min
pi
time
observ
vast
decreas
coloc
earli
endosom
marker
suggest
presenc
dextran
viru
intern
differ
pathway
trigger
anoth
question
whether
dextraninduc
micropinocytosi
may
initi
product
infect
address
question
cell
infect
presenc
dextran
nystatin
mitmab
nh
cl
infect
carri
day
cours
monitor
flow
cytometri
obtain
result
fig
clearli
show
although
viru
effect
enter
cell
macropinocytosi
abl
reach
replic
site
start
product
infect
inhibit
caveolindepend
endocytosi
presenc
dextran
block
viru
dextran
intern
block
viru
replic
remain
incessantli
one
import
etiolog
factor
respiratori
tract
diseas
human
consid
lack
effect
vaccin
therapeut
zoonot
potenti
anim
coronavirus
understand
viru
biolog
seem
import
mode
entri
remain
unknown
number
betacoronavirus
one
cousin
mous
hepat
viru
type
undergo
clathrinmedi
endocytosi
independ
sarscov
variou
pathway
report
intern
rout
three
human
betacoronavirus
merscov
describ
thu
far
work
delin
earli
step
infect
human
cell
first
aim
map
event
subsequ
virusreceptor
interact
check
whether
viru
abl
fuse
cellular
membran
cell
surfac
requir
prior
intern
gener
believ
intern
addit
stimuli
provid
due
acidif
microenviron
case
phdepend
activ
proteas
consequ
virus
sensit
inhibitor
prevent
ph
decreas
believ
requir
endocytosi
entri
show
bafilomycin
ammonium
chlorid
strongli
inhibit
viru
replic
fig
one
may
howev
question
whether
prolong
incub
viru
entri
affect
ensur
valid
observ
subcellular
local
virus
enter
cell
test
coloc
endosom
marker
verifi
obtain
result
confirm
virion
enter
cell
coloc
molecul
fig
establish
marker
earli
endosom
know
enter
cell
endocyt
rout
made
effort
delin
mechan
process
test
whether
viru
coloc
common
endocyt
marker
perform
research
reveal
interact
viru
cell
trigger
recruit
subsequ
caveola
assembl
fig
assembl
structur
depend
membran
content
flexibl
investig
influenc
compound
modifi
cholesterol
contentavail
entri
consist
nystatin
pretreat
caus
retent
viru
cell
surfac
fig
inhibitor
block
infect
prove
relev
pathway
viru
replic
fig
howev
known
chemic
inhibitor
may
show
nonspecif
effect
order
ensur
observ
effect
artifact
deplet
cell
use
rnai
technolog
fig
experi
consist
show
entri
depend
vesicl
cargo
track
traffick
replic
site
first
shown
newli
form
caveola
carri
virion
cut
cell
surfac
membran
dynamin
fig
dynamin
ringlik
shape
gtpase
drive
vesicl
scission
extens
studi
context
clathrindepend
endocytosi
also
demonstr
particip
caveola
trim
next
role
cytoskeleton
viru
transport
studi
interestingli
modif
actin
dynam
affect
viru
entri
actin
essenti
viru
intern
disrupt
actin
filament
result
inhibit
viru
entri
virion
coloc
cytoplasm
unstructur
actin
deposit
suggest
interact
viruscarri
vesicl
actin
filament
fig
hand
stabil
actin
cytoskeleton
result
retent
virion
cell
surfac
believ
may
link
physic
barrier
form
stabil
actin
cortex
fig
obtain
result
consist
literatur
data
test
coloc
dextran
previous
report
enter
cell
macropinocytosi
surpris
record
coloc
two
cargo
supplementari
fig
subsequ
examin
reveal
presenc
dextran
also
known
induc
macropinocytosi
viru
switch
intern
rout
macropinocytosi
supplementari
fig
seem
howev
viru
intern
rout
allow
effect
entri
replic
fig
one
may
hypothes
micropinocytosi
ph
vesicl
decreas
viru
cell
fusion
occur
scenario
virus
recycl
cell
surfac
degrad
intracellularli
interestingli
shown
mhv
sarscov
endocytosi
may
play
role
celltocel
spread
micropinocytosi
one
may
assum
may
differ
speci
studi
earli
step
replic
cycl
perform
cell
line
constitut
convent
accept
model
research
coronaviru
one
may
howev
question
whether
natur
system
human
airway
epithelium
hae
cultur
would
nt
appropri
unfortun
hae
cultur
support
replic
strain
replic
vitro
therefor
possibl
compar
two
model
direct
consequ
cell
cultur
adapt
recent
report
laboratori
strain
suggest
presenc
proteas
cell
surfac
modifi
entri
rout
allow
bypass
classic
endocyt
entri
similar
conclus
also
drawn
other
recent
provid
altern
explan
viru
conclus
result
allow
understand
first
step
infect
shown
follow
interact
receptor
protein
cell
surfac
viru
enter
cell
via
caveola
transport
along
actin
cytoskeleton
interestingli
shown
even
though
altern
entri
pathway
viru
event
lead
product
infect
dulbeccomodifi
eagl
medium
dmem
thermo
scientif
supplement
fetal
bovin
serum
fb
thermo
scientif
uml
penicillin
streptomycin
ciprofloxacin
cell
maintain
co
incub
atcc
propag
cell
dmem
supplement
fb
u
ml
penicillin
streptomycin
cell
lyse
day
infect
freez
thaw
cycl
viru
titrat
accord
reed
muench
formula
control
mockinfect
cell
use
viru
mock
aliquot
store
inhibitor
nystatin
ny
bafilomycin
bafa
cytochalasin
cytd
wortmannin
wort
purchas
sigma
aldrich
dynasor
dyn
mitmab
mm
purchas
abcam
jasplakinolid
jasp
merck
nh
cl
bioshop
stock
solut
prepar
either
dmso
jasp
pb
ny
cytd
wort
dyn
mm
nh
cl
store
accord
manufactur
recommend
viru
titrat
titrat
assay
perform
describ
previous
reed
muench
briefli
confluent
cell
cultur
plate
serial
fivefold
dilut
viru
stock
prepar
dmem
supplement
fb
uml
penicillin
streptomycin
dilut
viru
ad
well
cell
incub
co
day
cytopath
effect
occurr
score
use
invert
microscop
number
well
obviou
cytopath
effect
count
tcid
valu
calcul
accord
reedmuench
formula
coloc
assay
cell
seed
complet
medium
onto
glass
slide
plate
day
cell
cultur
medium
replac
serumfre
dmem
supplement
uml
penicillin
streptomycin
two
hour
prior
experi
next
cell
well
treat
stock
mock
incub
h
synchron
viral
particl
entri
cell
surfac
ctb
conjug
fitc
sigma
dilut
final
concentr
dmem
supplement
fb
uml
penicillin
streptomycin
use
posit
control
caveolindepend
entri
pathway
subsequ
cultur
transfer
indic
experi
pi
time
cell
wash
twice
pb
fix
cold
paraformaldehyd
least
min
room
temperatur
immunostain
visual
entri
inhibit
cell
seed
glass
slide
plate
cultur
h
time
media
remov
cell
incub
dmem
fb
uml
penicillin
streptomycin
supplement
endocytosi
inhibitor
h
subsequ
media
remov
stock
overlaid
cell
presenc
absenc
inhibitor
cultur
incub
h
unbound
viru
particl
remov
rins
cell
twice
pb
cell
cold
paraformaldehyd
least
min
room
temperatur
immunostain
actin
sirna
silenc
pool
sirna
target
scrambl
sirna
purchas
santa
cruz
biotechnolog
cell
cultur
glass
slide
plate
day
confluent
transfect
sirna
use
lipofectamin
rnaimax
thermo
fisher
scientif
accord
manufactur
instruct
final
amount
sirna
ad
well
pmol
procedur
repeat
h
later
improv
silenc
effect
reduc
protein
level
transfect
cell
infect
viral
stock
tcid
carri
h
later
h
cell
fix
immunostain
actin
describ
concomitantli
infect
day
protein
level
test
sampl
mocktransfect
nontransfect
cell
compar
western
blot
use
control
protein
isol
use
ripa
buffer
supplement
edta
proteinas
inhibitor
western
blot
analysi
cell
lysat
mix
sdspage
sampl
buffer
incub
min
afterward
separ
sdspage
electrophoresi
subsequ
electrotransf
onto
nitrocelulos
membran
amersham
membran
block
bsa
bioshop
trisbuff
salin
tween
tbst
membran
incub
primari
antibodi
antibodi
santa
cruz
biotechnolog
dilut
bsa
tbst
antibodi
santa
cruz
biotechnolog
dilut
bsa
tbst
h
wash
tbst
subsequ
membran
incub
hrplabel
antirabbit
igg
antibodi
sigma
dilut
bsa
tbst
h
final
signal
develop
use
ecl
system
amersham
inhibit
replic
endocytosi
inhibitor
cell
seed
plate
cultur
h
time
media
remov
cell
incub
dmem
fb
uml
penicillin
streptomycin
supplement
endocytosi
inhibitor
h
subsequ
media
remov
stock
tcid
overlaid
cell
presenc
absenc
inhibitor
cultur
incub
h
unbound
viru
particl
remov
rins
cell
thrice
pb
infect
cell
cultur
dmem
supplement
fb
uml
penicillin
streptomycin
presenc
inhibitor
day
final
inhibitor
cytotox
inspect
xtt
assay
mockinfect
cell
viral
rna
isol
cell
cultur
medium
yield
quantifi
rtqpcr
flow
cytometri
fac
analysi
three
day
post
infect
cell
harvest
trypsin
pellet
steril
pb
fixat
paraformaldehyd
cell
block
immunostain
describ
wash
resuspend
pb
cell
analyz
flow
cytometri
facscalibur
becton
dickinson
cell
quest
softwar
becton
dickinson
use
data
analysi
infect
rate
calcul
rel
untreat
infect
cell
quantit
real
time
pcr
viru
detect
quantif
perform
revers
transcript
reaction
follow
quantit
realtim
pcr
rtqpcr
viral
nucleic
acid
isol
cell
cultur
supernat
use
viral
dnarna
kit
biotechnolog
accord
manufactur
protocol
revers
transcript
carri
high
capac
cdna
revers
transcript
kit
thermo
fisher
scientif
accord
manufactur
protocol
serial
dilut
plasmid
carri
dna
n
gene
serv
standard
concentr
linear
form
standard
assess
use
spectrophotomet
gel
electrophoresi
subsequ
pcr
perform
use
kapa
probe
fast
qpcr
master
mix
kapa
biosystem
specif
probe
tga
cat
tgt
cga
tcg
gga
ccc
aag
ta
label
fam
tamra
primer
specif
forward
aac
cag
gct
gat
gtc
aat
revers
aga
cct
tcc
tga
gcc
ttc
rox
use
refer
dye
amplif
program
set
min
min
cycl
min
cell
viabil
assay
xtt
assay
cell
cultur
plate
describ
cell
viabil
examin
use
xtt
cell
viabil
assay
biolog
industri
accord
manufactur
protocol
briefli
medium
discard
dmem
supplement
fb
uml
penicillin
streptomycin
activ
xtt
solut
ad
well
h
incub
medium
transfer
onto
new
plate
signal
quantifi
nm
use
colorimet
flexstat
multimod
micropl
reader
molecular
devic
experi
perform
least
time
obtain
result
normal
control
sampl
cell
viabil
set
statist
analys
experi
perform
least
time
data
present
mean
triplic
sampl
sd
determin
signific
differ
compar
group
singlefactor
analysi
varianc
anova
appli
p
valu
consid
signific
data
avail
data
gener
analys
studi
includ
publish
articl
